Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.

ABSTRACT:

Background

Cardiac troponin concentrations are used to identify patients who would benefit from urgent revascularization for acute coronary syndromes. We hypothesized that they might be used in patients with stable ischemic heart disease to identify those at high risk for cardiovascular events who might also benefit from prompt coronary revascularization.

Methods

We measured the cardiac troponin T concentration at baseline with a high-sensitivity assay in 2285 patients who had both type 2 diabetes and stable ischemic heart disease and were enrolled in the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes trial. We tested for an association between the troponin T concentration and a composite end point of death from cardiovascular causes, myocardial infarc

SUBMITTER: Everett BM 

PROVIDER: S-EPMC4627639 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature